Attention-deficit/hyperactivity disorder and cardiometabolic risk profile in patients with acute myocardial infarction: data from the SWEDEHEART registry.

This study examines the associations between attention-deficit/hyperactivity disorder (ADHD) and the cardiometabolic risk profile, participation in non-pharmacological interventions, and long-term outcomes in patients with myocardial infarction (MI).There were limited differences in clinical parameters and disease histories between adults with MI with and without ADHD, except for a higher risk proportion of previous bleeding and chronic obstructive pulmonary disease in those with ADHD.Adults with MI and ADHD exhibited a higher risk of smoking and snus use and were less likely to engage in follow-up evaluations or quit smoking, underscoring the need for improved targeted secondary prevention measures.ADHD was not associated with subsequent recurrent cardiovascular events, but there was a higher risk of all-cause mortality after MI.